Jean-Pierre Wery
Vorsitzender bei CROWN BIOSCIENCE INTERNATIONAL
Ursprung des Netzwerks ersten Grades von Jean-Pierre Wery
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Biotechnology | 18 | |
Crown Bioscience San Diego, Inc.
1
| Subsidiary | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jean-Pierre Wery
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Chief Executive Officer | |
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Founder Founder Chairman Chief Executive Officer Director/Board Member Director/Board Member Director of Finance/CFO Chief Executive Officer | |
Applied StemCell, Inc.
Applied StemCell, Inc. BiotechnologyHealth Technology Applied StemCell, Inc. is a biotechnology company. Its products include stem cell research, genome editing products for cell line generation, primary cells from patient samples and isogenic cell lines. The company was founded by Ruhong Jiang, Ruby Yanru Chen-Tsai and Michael Cleary and is headquartered in Milpitas, CA. | Biotechnology | Director/Board Member | |
Waterstone Pharmaceuticals, Inc.
Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Founder Director/Board Member | |
NVIGEN, Inc.
NVIGEN, Inc. Medical SpecialtiesHealth Technology NVIGEN, Inc. develops multifunctional and biodegradable nanoparticles. Its products include MagVigen, MaxVigen, MyQuVigen, and AuVigen. The company was founded by Aihua Fu and Guo Liang Yu and is headquartered in Campbell, CA. | Medical Specialties | Founder | |
QuanDx, Inc.
QuanDx, Inc. Medical SpecialtiesHealth Technology QuanDx, Inc. provides molecular diagnostics. It specializes in the development and commercialization of novel diagnostic tools. The firm provides diagnostic and prognostic information for hematological and solid tumor cancers, as well as a number of infectious diseases. The company was founded by Matthew Lei and Guo-Liang Yu in 2012 and is headquartered in San Jose, CA. | Medical Specialties | Founder | |
CHUNGHWA TELECOM CO., LTD. | Major Telecommunications | Director/Board Member | |
QISDA CORPORATION | Computer Processing Hardware | Director/Board Member | |
ACER INCORPORATED | Computer Processing Hardware | Director of Finance/CFO | |
TEST-RITE INTERNATIONAL CO., LTD. | Wholesale Distributors | Director of Finance/CFO | |
SINYI REALTY INC. | Real Estate Development | Director/Board Member | |
Terragen Discovery, Inc.
Terragen Discovery, Inc. Pharmaceuticals: MajorHealth Technology Part of Cubist Pharmaceuticals LLC, Terragen Discovery, Inc. is a developer of antibiotics and patent drugs. The company is based in Vancouver, Canada. Terragen Discovery was acquired by Cubist Pharmaceuticals LLC on October 26, 2000 for $25.61 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
TTY BIOPHARM COMPANY LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
University of the Pacific
University of the Pacific Other Consumer ServicesConsumer Services University of the Pacific is a nationally ranked university with a long tradition of dedicated teaching, small class sizes, practical experience and vibrant residential life. The breathtaking main campus in Stockton, California is home to seven schools and colleges, with more than 80 majors and programs of study. Pacific also has the McGeorge School of Law in Sacramento and the Arthur A. Dugoni School of Dentistry in San Francisco. Total university enrollment is nearly 7,000, with 3,757 undergraduates in an average class size of 19 and a student/faculty ratio of 14:1. It is located in Stockton, California. | College/University | Director/Board Member | |
University of Denver | College/University | Masters Business Admin | |
University of Sussex | College/University | Doctorate Degree | |
National Taiwan University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Tsinghua University | College/University | Masters Business Admin | |
China Europe International Business School | College/University | Masters Business Admin | |
Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
Starvax, Inc. | Corporate Officer/Principal Founder | ||
National Foundation for Cancer Research
National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services The National Foundation for Cancer Research is a non-profit organization that provides funding to scientists for cancer research. The non-profit company is based in Bethesda, MD. The company's mission is to support life-saving discoveries for cancer patients. | Miscellaneous Commercial Services | Director/Board Member | |
Shenzhen Yuanxing Biomedical Technology Co., Ltd.
Shenzhen Yuanxing Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Tsinghua Yuanxing Biotechnology, Inc. is engaged in the development of biological and pharmaceutical products. It is involved in the research and development, commercialization of adenoviral vector vaccine. The company was founded on December 4, 2000 and is headquartered in Shenzhen, China. | Biotechnology | Corporate Officer/Principal | |
Sun Yat-Sen University | College/University | Undergraduate Degree | |
ANZ Banking Corp.
ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Regional Banks | Director/Board Member | |
The BayHelix Group | Corporate Officer/Principal Chairman | ||
The Chinese Biopharmaceutical Association | Founder | ||
TWI PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
The Chinese-American Biopharmaceutical Society
The Chinese-American Biopharmaceutical Society Pharmaceuticals: MajorHealth Technology The Chinese-American Biopharmaceutical Society is a non-profit organization for professionals in the biopharmaceutical industry. The non-profit company is based in San Francisco, CA, the birthplace of biotechnology and one of the largest biomedical hubs in the world. The company's membership consists of life science professionals from a broad range of experience levels, with a large percentage of members holding senior or executive positions in the industry. The society offers year-round sponsorship opportunities, including the highly anticipated 2023 annual BioPacific Conference, and leverages an extensive network of life sciences professionals. | Pharmaceuticals: Major | Director/Board Member | |
Ray Wu Memorial Fund | Director/Board Member | ||
LUMOSA THERAPEUTICS CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
PLEXBIO CO., LTD. | Medical Specialties | Director/Board Member | |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Executive Officer | |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Founder | |
Beijing Percans Oncology Co., Ltd.
Beijing Percans Oncology Co., Ltd. Hospital/Nursing ManagementHealth Services Beijing Zhikang Boyao Oncology Research Co. Ltd. operates medical oncology center for chemotherapy cancer patients. It engages in the research and development for cancer treatment and tumor transplantation through i-graft tumor transplantation model. The company was founded by Chen Yi You in December 2012 and is headquartered in Beijing, China. | Hospital/Nursing Management | Founder | |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Pharmaceuticals: Major | Founder | |
BIOGEND THERAPEUTICS CO., LTD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Zhejiang Crownmab Biotech Co. Ltd. | Chairman | ||
Alpine BioTherapeutics Corp.
Alpine BioTherapeutics Corp. BiotechnologyHealth Technology Alpine BioTherapeutics Corp. engages in the development of stem cell-based therapy to treat blindness. The company was founded by Jiagang Zhao and Ying Wu in 2017 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Hangzhou New Horizon Health Technology Co., Ltd.
Hangzhou New Horizon Health Technology Co., Ltd. Medical SpecialtiesHealth Technology Hangzhou New Horizon Health Technology Co., Ltd. is a private company that develops, manufactures, and wholesales medical diagnostics equipment for cancer screening. The company is based in Hangzhou, China. | Medical Specialties | Director/Board Member | |
Cothera Bioscience, Inc.
Cothera Bioscience, Inc. BiotechnologyHealth Technology Cothera Bioscience, Inc. is a Chinese clinical stage biotechnology company that develops therapeutics. The company is based in [city], [country]. The company was founded in [year] by [founders' names]. Yue Wu has been the CEO since [year]. | Biotechnology | Chief Executive Officer Founder | |
Nhjk Holding Corp. Ltd. | Director/Board Member | ||
Nh Health Usa, Inc. | Director/Board Member | ||
CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Founder | |
Connect Biopharma HongKong Ltd. | Director/Board Member | ||
Innoforce Pharmaceuticals Co. Ltd.
Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Pharmaceuticals: Major | Founder |
Statistik
International
Vereinigte Staaten | 23 |
Taiwan | 12 |
China | 12 |
Hong Kong | 3 |
Kanada | 2 |
Sektoral
Health Technology | 22 |
Consumer Services | 10 |
Commercial Services | 5 |
Finance | 4 |
Electronic Technology | 3 |
Operativ
Director/Board Member | 93 |
Chairman | 38 |
Founder | 30 |
Independent Dir/Board Member | 20 |
Chief Executive Officer | 14 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jung Chin Lin | 49 |
Guo-Liang Yu | 27 |
Chih Kai Cheng | 16 |
Yue Wu | 16 |
Hai Yi Ma | 16 |
Yi You Chen | 15 |
Wubin Pan | 10 |
Eva Ho | 7 |
Lou Yu Yan | 7 |
Fa Ming Zhang | 7 |
Ping Chu | 5 |
Chia Hsin Li | 5 |
Sandy Chau | 3 |
Chia Jung Li | 3 |
Hsiao Tien Hsu | 2 |
- Börse
- Insiders
- Jean-Pierre Wery
- Unternehmensverbindungen